Antimelanocyte antibodies: A possible role in patients with vitiligo | Zendy

Mohammad A. Gaballah | Zendy; MahaA El-Gayyar | Zendy; ManalE Helmy | Zendy; EmanR Amer | Zendy; M el-Saied | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antimelanocyte antibodies: A possible role in patients with vitiligo

Author(s) -

Mohammad A. Gaballah,

MahaA El-Gayyar,

ManalE Helmy,

EmanR Amer,

M el-Saied

Publication year - 2020

Publication title -

indian journal of dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.395

H-Index - 36

eISSN - 1998-3611

pISSN - 0019-5154

DOI - 10.4103/ijd.ijd_344_18

Subject(s) - vitiligo , medicine , pathogenesis , autoantibody , immunology , anti nuclear antibody , antibody , disease , alopecia areata , dermatology , pathology

Vitiligo is an acquired depigmenting skin disorder with multifactorial pathogenesis including genetic, autoimmune, and neuronal factors. Both humoral- and cell-mediated immunities are supposed to have a role in the pathogenesis of vitiligo. Patients with vitiligo have an increased concentration of circulating autoantibodies that are specific to melanocyte cytoplasm and surface antigens that related to the extent of the disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research